CellAegis Completes Patient Enrollment in Trial

CellAegis completed its patient enrollment in a large-scale, UK investigator-sponsored trial to further assess the efficacy of remote ischemic conditioning (RIC) in reducing clinical events in patients presenting with STEMI in patients receiving treatment in hospital catheterization labs or emergency rooms.

Click here for more details.

Previous
Previous

Seeking Digital Health Companies for Springboard Health Hub

Next
Next

Ontario Announces Trade Mission to RESI Boston, September 2018